COMMUNIQUÉ DE PRESSE publié le 10/10/2025 à 17:59, il y a 1 année Fuller, Smith & Turner PLC: Transaction in own shares Fuller, Smith & Turner PLC announces purchase of own shares as part of buyback program. Company holds repurchased shares in Treasury Share Buyback Program Fuller, Smith & Turner PLC Treasury Shares Numis Securities Limited Company Announcement
BRÈVE publiée le 09/10/2025 à 18:28, il y a 1 année Fuller, Smith & Turner PLC Conducts Share Buyback Voting Rights London Stock Exchange Share Buyback Treasury Shares Fuller’s
BRÈVE publiée le 09/10/2025 à 18:28, il y a 1 année Fuller, Smith & Turner PLC procède à un rachat d'actions Actions Propres Rachat D'actions Droit De Vote Bourse De Londres Fuller
COMMUNIQUÉ DE PRESSE publié le 09/10/2025 à 18:23, il y a 1 année Fuller, Smith & Turner PLC: Transaction in own shares Fuller, Smith & Turner PLC announces purchase of 16,500 'A' Ordinary Shares at an average price of 599.9394 GBp each as part of share buyback program London Stock Exchange Voting Rights Disclosure Share Buyback Program Numis Securities Limited Fuller Smith Turner PLC
BRÈVE publiée le 08/10/2025 à 18:14, il y a 1 année Fuller, Smith & Turner Engages in Share Buyback London Stock Exchange Share Buyback Treasury Shares Numis Securities Fuller Smith & Turner
BRÈVE publiée le 08/10/2025 à 18:14, il y a 1 année Fuller, Smith & Turner procède à un rachat d'actions Actions Propres Rachat D'actions Numis Securities Bourse De Londres Fuller Smith & Turner
COMMUNIQUÉ DE PRESSE publié le 08/10/2025 à 18:09, il y a 1 année Fuller, Smith & Turner PLC: Transaction in own shares Fuller, Smith & Turner PLC announces purchase of own shares as part of buyback program, holding repurchased shares in Treasury, details of transactions provided Treasury Fuller, Smith & Turner PLC Purchase Buyback Program Transaction Details
BRÈVE publiée le 07/10/2025 à 18:39, il y a 1 année Fuller, Smith & Turner PLC Executes Share Buyback London Stock Exchange Share Buyback Treasury Shares Market Regulation Fuller's Smith & Turner
BRÈVE publiée le 07/10/2025 à 18:39, il y a 1 année Fuller, Smith & Turner PLC procède à un rachat d'actions Actions Propres Rachat D'actions Bourse De Londres Régulation Du Marché Smith & Turner De Fuller
COMMUNIQUÉ DE PRESSE publié le 07/10/2025 à 18:34, il y a 1 année Fuller, Smith & Turner PLC: Transaction in own shares Fuller, Smith & Turner PLC announces purchase of own shares as part of share buyback programme. Company to hold repurchased shares in Treasury Treasury Numis Securities Limited Fuller Smith Turner PLC Share Purchase Shares Buyback
Publié le 04/11/2026 à 18:00, il y a 9 heures 9 minutes The Belgian State and Engie Group have agreed to extend the target date for concluding the Heads of Terms until 12 December 2026
Publié le 04/11/2026 à 18:00, il y a 9 heures 9 minutes L’État belge et le groupe ENGIE ont convenu de se donner un délai supplémentaire jusqu’au 12 décembre 2026 pour la conclusion des Heads of Terms
Publié le 04/11/2026 à 17:44, il y a 9 heures 25 minutes Aéroports de Paris SA - Information regarding the voting rights and shares as of 31 October 2026
Publié le 04/11/2026 à 23:10, il y a 3 heures 59 minutes Ur-Energy Announces Date for Third Quarter 2026 Results and Conference Call and Webcast
Publié le 04/11/2026 à 23:00, il y a 4 heures 9 minutes Viemed Healthcare Announces Third Quarter 2026 Financial Results
Publié le 04/11/2026 à 22:15, il y a 4 heures 54 minutes Zomedica Announces Record Third Quarter Revenue of $9.9 Million, Up 22% Year-Over-Year, Net Loss Reduced 48%, with $41 Million in Liquidity
Publié le 04/11/2026 à 22:05, il y a 5 heures 4 minutes Stabilis Solutions Announces Third Quarter 2026 Results
Publié le 05/11/2026 à 00:02, il y a 3 heures 7 minutes EQS-Adhoc: NEXTDC Limited: Response to Share Raid by Goodman Group and Digital Realty
Publié le 04/11/2026 à 19:41, il y a 7 heures 28 minutes EQS-Adhoc: SNP SE Raises Outlook for the Full Year 2026
Publié le 04/11/2026 à 19:25, il y a 7 heures 44 minutes Menarini Group and Ryvu Therapeutics Announce First Clinical Data from the Phase II JASPIS-01 Study of dapolsertib (MEN1703, SEL24) in Heavily Pretreated Relapsed/Refractory Aggressive B-cell non-Hodgkin Lymphoma at the 2026 ASH Annual Meeting
Publié le 04/11/2026 à 18:43, il y a 8 heures 26 minutes EQS-Adhoc: Deutsche EuroShop refines its revenue forecast and raises its earnings forecast for the 2026 financial year
Publié le 04/11/2026 à 18:05, il y a 9 heures 4 minutes Redis Expands Redis Iris to Give AI Agents the Memory, Context, and Messaging They Need to get to Production
